Home > Insider Trading > Filing (0001104659-25-051163)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1526119	Verastem Inc.	VSTM	Pharmaceutical Preparations (2834)	273269467

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1951861	Daniel Calkins	C/O Verastem, Inc., 117 Kendrick St., Suite 500 Needham MA 02494	Chief Financial Officer	No	Yes	No	No

Transaction Summary

Sold:	11,143 shares	Avg. Price: $8.13	Total Value: $90,592.59
Number of Shares After Transactions:	114,055 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-05-16	38,850	$0.00	125,198	No	4	A	Direct
Common Stock	Disposition	2025-05-20	11,143	$8.13	114,055	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

The reported securities were subject to a performance RSU award that was granted on June 18, 2024. 150,000 RSUs vested on May 16, 2025, upon the Issuer's Compensation Committee of the board of directors determining the performance criteria of approval by the FDA of an NDA for the Company's combination therapy of avutometinib and defactinib for the treatment of low-grade serous ovarian cancer had occurred.
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.